Mount Sinai Health System sells 10.4 million in GeneDx shares - Investing.com
| WGSWW Stock | 0.17 0.02 13.33% |
Slightly above 57% of all GeneDx Holdings' sophisticated investors are looking to take a long position. The analysis of the overall investor sentiment regarding GeneDx Holdings Corp suggests that some traders are interested. GeneDx Holdings' investing sentiment can be driven by a variety of factors including economic data, GeneDx Holdings' earnings reports, geopolitical events, and overall market trends.
GeneDx |
Mount Sinai Health System sells 10.4 million in GeneDx shares Investing.com
Read at news.google.com
 |
GeneDx Holdings Fundamental Analysis
We analyze GeneDx Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneDx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneDx Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
GeneDx Holdings is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
GeneDx Holdings Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeneDx Holdings stock to make a market-neutral strategy. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics with similar companies.
Peers
GeneDx Holdings Related Equities
| PRVA | Privia Health | 3.86 | ||||
| CERT | Certara | 0.71 | ||||
| NRC | National Research | 0.56 | ||||
| DH | Definitive Healthcare | 0.21 | ||||
| HSTM | HealthStream | 0.18 | ||||
| EUDA | EUDA Health | 2.93 | ||||
| HCTI | Healthcare Triangle | 7.25 | ||||
| FOXO | FOXO Technologies | 11.54 |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.